What is Feel Therapeutics?
Feel Therapeutics operates at the intersection of digital precision medicine and mental health informatics. The company specializes in the development of sophisticated platforms that utilize passive monitoring to provide clinicians and patients with objective, real-time data. By moving away from subjective self-reporting, Feel Therapeutics aims to enhance diagnostic accuracy and personalize treatment plans for complex mental health conditions. This enterprise-level approach positions the firm as a critical player in the shift toward data-driven, proactive healthcare delivery, effectively bridging the gap between clinical research and daily patient management.
How much funding has Feel Therapeutics raised?
Feel Therapeutics has raised a total of $10.3M across 1 funding round:
Angel/Seed
$10.3M
Angel/Seed (2019): $10.3M with participation from SOSV, Anthemis Exponential Ventures, and Felicis Ventures
Key Investors in Feel Therapeutics
SOSV
SOSV is a multi-stage venture capital investor that provides intellectual and financial capital to accelerate founders big ideas.
Anthemis Exponential Ventures
A venture capital firm focused on the intersection of financial services and technology, often backing companies that drive systemic change.
Felicis Ventures
Felicis is a Menlo Park-based venture capital firm that raises multi-stage funds to invest in early and growth-stage technology companies across sectors such as SaaS, AI, and fintech.
What's next for Feel Therapeutics?
With the recent injection of capital, Feel Therapeutics is well-positioned to scale its enterprise operations and expand its clinical footprint. The strategic focus will likely shift toward deepening its integration with existing healthcare systems and accelerating the validation of its monitoring algorithms across diverse patient populations. As the company transitions from its foundational development phase into a period of rapid commercialization, the emphasis will remain on proving the efficacy of its digital biomarkers in improving patient outcomes. Future growth will be defined by the company's ability to navigate regulatory landscapes while maintaining its competitive edge in the rapidly evolving digital therapeutics market.
See full Feel Therapeutics company page
